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AbstrACt
Objectives To understand stakeholders’ views 
regarding the content and design of paediatric clinical 
trial multimedia websites. To describe how this 
knowledge informed the development of the multimedia 
websites.
Design Qualitative study comprising two rounds of 
interviews or focus groups, with thematic analysis of 
interview transcripts.
Participants Sixty-two people (21 children and young 
people with long-term health conditions, 24 parents and 
17 professionals).
setting One UK children’s hospital and one UK Young 
Persons’ Advisory Group.
results When asked what was important in deciding 
whether to join a trial, children, young people and parents 
prioritised information about what participation would 
involve, what the trial was testing, potential benefits and 
risks of participation and knowing they could leave the 
trial if they later changed their minds. Young people and 
parents trusted trial teams to follow regulatory and quality 
requirements and therefore did not think such information 
was a priority for the websites, although logos of trusted 
organisations could lend credibility. Professionals largely 
concurred with these views. Children and young people 
advised on the importance of designing the multimedia 
website to ensure its appearance, tone and wording suited 
the intended audience and on using animated characters 
to facilitate children’s engagement.
Conclusions Our study provides insights into the 
information that families value when deciding about 
healthcare trial participation. It provides guidance on the 
design of information resources to appeal to children and 
young people, while also being acceptable to parents and 
professionals who are often gatekeepers of children’s 
access to information. Our findings will be of use to others 
developing similar multimedia websites. We report specific 
information needs and new visual preferences that are not 
usually addressed in printed trial information. Our work 
illustrates what qualitative research and participatory 
design practices can contribute to the development of 
information resources more generally.
trial registration number ISRCTN73136092; Pre-results.
IntrODuCtIOn 
High-quality clinical trials involving children 
are essential to ensure that medication and 
treatments for children are effective and 
safe.1–4 Conventionally, participant informa-
tion about trials is provided in printed form. 
These documents should be understandable 
to potential participants and assist their deci-
sion making.5 It is recognised that children 
and young people should have opportuni-
ties to understand what any research would 
entail and participate in the decision-making 
process.6 However, as with adult studies,7 
printed participant information sheets for 
paediatric clinical trials are often lengthy 
and difficult to read and understand.8 9 This 
strengths and limitations of this study
 ► This is the first UK study to explore and apply knowl-
edge about stakeholders’ views to inform the de-
velopment of multimedia websites that aim to help 
children and young people decide about clinical trial 
entry.
 ► We worked to make the research process interactive 
and engaging, particularly for children and young 
people, by using activities and examples of web-
sites, animations and characters.
 ► Limitations included that some of the younger chil-
dren had difficulty engaging during the interviews.
 ► Sampling was limited to two regions of the UK, and 
we did not interview many children and young peo-
ple with long-term health conditions aged between 
9 years and 14 years. However, we interviewed chil-
dren, young people and parents with trial experience 
as well as those who had not previously participated 
in a trial.
 ► The findings enabled us to develop the multimedia 
websites to suit the needs and preferences of chil-
dren, young people and their parents and identify 
ways that the multimedia websites could enhance 
their engagement in decisions about trials.
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has implications for children and young people’s under-
standing of trials, which may affect their decision to 
participate. Several studies have identified gaps in chil-
dren’s understanding about the purpose of trials and of 
what participation in a trial entails.10 11 A recent review 
has highlighted the importance of providing information 
about research to children and young people directly, not 
just via parents, and advocates that printed information is 
written in a way that is ‘appealing and understandable’ to 
children and young people.12 The limitations of printed 
media for informing potential trial participants about 
trials has been recognised by the UK Health Research 
Authority, who recommend exploration of the usefulness 
of other media.13 A novel approach for providing infor-
mation to potential trial participants is to use multimedia 
websites, which allow information to be presented using 
animation, video, text and images. Multimedia websites 
have been beneficial in informing potential participants 
and recruiting participants to studies,11 14 15 although 
work describing the development of such resources for 
children and young people is limited.
This paper addresses this gap by reporting on a qualita-
tive interview and focus group study with children, young 
people, parents and professionals to inform the develop-
ment of the multimedia websites for use in paediatric clin-
ical trials. This study was part of the TRials Engagement 
in Children and Adolescents (TRECA) project,16 which 
also involves the development and subsequent evaluation 
of the impact of multimedia websites on recruitment, 
retention and decision-making in paediatric trials. The 
current qualitative study drew on the principles of partic-
ipatory design to help ensure that the newly developed 
multimedia websites would meet the needs and prefer-
ences of children and young people being approached to 
participate in trials while also being acceptable to parents 
and professionals. The acceptability of such materials to 
parents and professionals is important as they are gate-
keepers to children’s access to information about clinical 
trials or treatment options.17 Here we describe the find-
ings from the qualitative study and how we used these to 
inform the development of the multimedia websites.
MethODs
This study involved two rounds of interviews (individual, 
joint or focus group discussions). The first round focused 
on identifying participants’ needs and preferences for 
information about clinical trials, while the second round 
sought their views of prototype multimedia websites that 
had been developed based on feedback from the first 
round of interviews. We aimed to involve participants in 
both rounds to facilitate the iterative development of the 
multimedia websites, with some replacement of partici-
pants for the second round, when required.
sampling and recruitment of participants
We recruited children, young people and parents 
through two routes: a children’s hospital in North West 
England and a Generation R Young Persons’ Advisory 
Group (YPAG) located in the Midlands, comprising 
children and young people who advise on the design 
of research involving children and young people in the 
NHS. Recruitment via the hospital route involved nurses 
contacting families of children who were receiving special-
ised care for long-term conditions, either by phone or in 
person; the YPAG route involved the YPAG coordinator 
contacting members and their parents by text message 
or by phone call. The interviewer (JMM-K) telephoned 
those who agreed to contact to explain the study and 
arrange a time for an interview. Sampling of children, 
young people and parents aimed to encompass variation 
in age, gender, long-term health condition, trial experi-
ence and ethnicity. Professionals were initially emailed by 
an academic paediatrician working in the study hospital. 
Those who expressed an interest were subsequently 
contacted by JMM-K by email to arrange the interviews. 
Sampling of professionals aimed for diversity in roles and 
paediatric specialities within trial settings.
We provided participants with printed information 
sheets about the study, with different versions for chil-
dren, young people, parents and professionals. Partici-
pants under 16 years provided assent, and their parents 
provided consent for the child or young person’s partic-
ipation. All participants received a £10 gift voucher after 
being interviewed.
Data collection
We undertook topic-guided, semistructured interviews with 
children and young people with long-term health condi-
tions, their parents and professionals. Interviews were 
conducted by the same interviewer (JMM-K) over the two 
rounds (July–October 2016 and November 2016–January 
2017). JMM-K is a research lead on the study with a science 
background and training in qualitative research meth-
odology; she had undertaken and analysed focus groups 
previously and BY and KA both provided advice and guid-
ance. JMM-K explained at the start of interviews that all 
comments were welcomed and that a key aim of the inter-
views was to inform the development of the websites to suit 
potential end users. All interviews and focus groups were 
audio-recorded and transcribed; transcripts were checked 
and pseudoanonymised before analysis.
First round of interviews
JMM-K began interviews narratively by asking participants 
about their experience of research and involvement in 
health research. Later in the interviews, she showed all 
participants 20 cards with topics that adults had previ-
ously identified as being important when deciding to 
take part in a trial18 and asked them to rank the topics 
(see box 1) as ‘important’, ‘somewhat important’ and 
‘not important’.19 20 JMM-K also asked participants to 
comment on their rankings and on any information not 
included in the cards that they felt was important when 
deciding whether to participate in a trial. Research is 
quite an abstract and challenging topic particularly 
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for younger participants, and this exercise helped to 
facilitate discussion and support participants in iden-
tifying what was important to them.21 To similarly facil-
itate participants discussing their preferences regarding 
different designs of multimedia websites, JMM-K showed 
participants various examples of existing websites, anima-
tions and a video (see table 1 for details) and examples of 
character designs (figure 1) and asked them to comment 
on these. These examples represented a range of presen-
tation styles and design styles.
Finally, we explored how the multimedia websites should 
look and function by asking participants to rank six cards, 
each with a printed statement related to criteria for assessing 
websites.22 These covered content, structure and naviga-
tion, visual design, interactivity, functionality and credibility. 
An initial analysis of the first round of interviews informed 
the design of the prototype multimedia websites.
second round of interviews
In the second round of interviews, we explored partici-
pants’ views of the prototype multimedia websites. We 
developed the topic guides based on input from a quali-
tative methodologist (BY) with experience of researching 
families’ decisions about clinical trial participation and 
an education expert (SH). The websites concerned a 
paediatric diabetes trial,23 with one version aimed at chil-
dren aged 6–11 years and their parents and the other at 
young people aged 12 years upwards and their parents. 
The multimedia websites included two animations that 
were not age specific: a trial-specific ‘explainer’ anima-
tion that summarised the diabetes trial and a generic 
‘why do we do trials’ animation that outlined the ratio-
nale for conducting a trial. We showed participants the 
animations and the multimedia website suited to their 
age (and the other version if they wished; see figures 2 
and 3) and explored their views of these (see box 2 for 
prompts). We also invited suggestions to improve the 
multimedia websites and animations. We waited until 
this second round when we had concrete materials avail-
able before interviewing young children (6–8 years old) 
and their parents, as we felt the content covered in the 
first round of interviews would be too abstract to engage 
young children.
Data analysis to inform the development of the multimedia 
websites
We conducted an initial rapid descriptive data analysis24 
in order to provide timely feedback to the company 
developing the multimedia websites. This analysis was 
deductive and focused on the content and design aspects 
of the website. Subsequent analyses were iterative and 
thematic with both inductive and deductive aspects.25 26 
This involved reading transcripts multiple times to aid 
box 1 topics within first round of interviews and focus 
group discussions
 ► Why is the study happening?
 ► Why have I been invited?
 ► Do I have to take part?
 ► What will happen if I do not want to carry on with the study?
 ► What will happen to me if a take part?
 ► Will it cost me any money to take part?
 ► Will I be paid for taking part?
 ► What is being tested in the study (for example what drug or device)?
 ► What are the different treatments or types of healthcare being pro-
vided in the study?
 ► What are the risks of taking part?
 ► What are the possible benefits of taking part?
 ► What happens when the study ends?
 ► What would happen if a problem happens in the study/could I make 
a complaint?
 ► Will my taking part be kept confidential (private)?
 ► Will my general practitioner/family doctor be told about my taking 
part?
 ► What will happen to any blood tests or other samples that I have as 
part of the study?
 ► What will happen to the results of the study?
 ► Who is running the research?
 ► Who is paying for the research?
 ► Who has reviewed the study?
Table 1 Resources used within the first round of interviews
Resource Example of: Link
HeadSpace Website https://www.headspace.com/
Toca Website https://tocaboca.com/
Health Research: making the right 
decision for me (Nuffield Council on 
Bioethics)
Animation https://www.youtube.com/watch?v=6yaKwLG_vlE
What is a randomised trial? (Cancer 
Research UK)
Animation http://www.cancerresearchuk.org/about-cancer/find-a-clinical-
trial/what-clinical-trials-are/randomised-trials
Can we tell which children with 
febrile neutropaenia have a bad bug 
or infection? (Dr Bob Phillips)
Animation (Lego) https://www.youtube.com/watch?v=Z1AXzJqatds
Hi-Light Trial video Video of child and 
parent talking about 
participating in the trial
Video not publicly available. Hi-Light protocol is available.27
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familiarisation, followed by line-by-line coding to iden-
tify recurring ideas and organising these into themes and 
subthemes. We also compared interviews across partici-
pant groups to identify similarities and differences. Anal-
ysis was undertaken by JMM-K with guidance provided via 
regular meetings with BY and KA to discuss transcripts 
and aid data interpretation. As we outline below, findings 
from the data analysis were also discussed with the TRECA 
Study Patient and Parent Advisory Group to seek their 
thoughts on ways to implement feedback received from 
the qualitative study in the development of the multi-
media websites. Data coding and indexing was assisted 
by Microsoft Excel 2010 software. JMM-K drafted several 
iterations of a data analysis report, which BY, KA and PK 
read and discussed.
Patient involvement
Patient and public involvement informed the overall 
research questions within TRECA from its inception and 
particularly during the grant-writing stage. The TRECA 
Study also convened an active and engaged Patient and 
Parent Advisory Group to give input throughout the study 
and suggest ways to implement changes requested by 
participants in the qualitative study. One of the members 
(DHT) of the Patient and Parent Advisory Group is an 
author on this manuscript. Children, young people, 
parents and professionals who participated in this study 
will be invited to attend a presentation about the findings 
of the study or to receive reader-friendly summaries of the 
study as they prefer.
results
Participants
Across the two rounds of interviews, a total of 87 people 
were invited to participate, and 62 were interviewed. Of 
the 87 people invited, 35 were professionals of whom 17 
were interviewed; those who declined were either unavail-
able for interview or did not respond. Twenty-eight 
parents were invited with 24 taking part; and 24 young 
people were invited to participate with 21 participating. 
Those who declined did so either due to other commit-
ments or because they did not want to participate. Of the 
62 participants, 15 participated in round 1 only (6 chil-
dren and young people, 6 parents and 3 professionals), 
22 in round 2 only (10 children and young people, 10 
parents and 2 professionals) and 25 in both rounds (5 
children and young people, 8 parents and 12 profes-
sionals). Table 2 provides a summary of the participant 
characteristics and online supplementary appendix 1 
shows detailed participant characteristics. Of the 21 chil-
dren and young people interviewed, 16 preferred to be 
interviewed with a parent(s) present. The five young 
Figure 1 Character design options.
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people who were members of the YPAG preferred to take 
part in focus group interviews, as did all but three profes-
sionals. Focus groups had between four and nine partic-
ipants. One participant was interviewed individually via 
Skype; all other interviews were face to face in a private 
room while attending hospital or YPAG meeting. Chil-
dren and young people had a range of long-term health 
conditions including arthritis, asthma, cancer, as well as 
neurological and muscular conditions.
Findings
Based on both rounds of interviews, we describe below 
what information participants felt was important when 
considering participation in a trial, their preferences 
regarding the design, tone and wording of the multimedia 
websites and how this knowledge informed the devel-
opment of the websites. A striking overarching finding 
was that most participants spoke about the need for the 
views and preferences of children and young people to 
be central in the design of multimedia websites. As one 
parent commented:
It’s more important to get across to the teenagers be-
cause it’s the teenagers who are going through it, you 
know, the parents are just a by-product of what is hap-
pening. (Parent/33)
While the aspiration to prioritise children and young 
people’s views may have shaped participants’ accounts, 
nevertheless, we also outline areas where the various 
participant groups (children, young people, parents and 
professionals) differed in their views of the content and 
design of multimedia websites. Given the gatekeeping role 
of parents and professionals and potential to constrain 
children’s and young people’s access to multimedia 
websites, taking account of such differences is important.
Content of the multimedia websites
In the sections that follow, we outline what informa-
tion participants regarded as important and what they 
regarded as of little or no importance.
That you can leave a trial
A particularly important piece of information for children 
and young people was knowing that even after joining a 
trial they could later change their mind and leave. Chil-
dren and young people who had been in a trial in partic-
ular often emphasised the importance of knowing that 
it was ‘okay’ to leave the trial at any time. For example, 
knowing they were free to leave if the treatment subse-
quently caused significant side effects helped them to 
feel safe to say ‘yes’ to a trial. One young person said that 
this information was her only priority. Professionals also 
Figure 2 Website for children and their parents.
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ranked this as an important aspect for families and said 
that they emphasised it during their initial discussions 
with families about trials.
Knowing that you can stop at any time is also good 
because say you just didn’t want it anymore and you 
were getting bad side effects and you didn’t like it, 
then they could stop it just then and there. (CYP/16)
If I don’t feel comfortable in the trial anymore or if I 
didn’t want to take part because I didn’t think it was 
working for me, could I just stop it – and they were re-
ally good at explaining that you could just stop at any 
time that you wanted and you just have to let them 
know… so that was one of the only questions that I 
had really. (CYP/23)
We therefore made the information that participants 
could leave the trial at any time and do not need to provide 
a reason prominent within the multimedia websites.
What is involved if I participate?
Children, young people and their parents wanted to 
understand what participation in a trial involved. Several 
who had previously been approached about a trial 
commented that they would have liked to know more 
about what was going to be required of them than they 
had been provided with when they were approached 
about a trial. Young people particularly wanted detailed 
information about the number of clinic or hospital visits, 
whether they would need to have time away from school 
and detail about what the treatments involved, including 
what children would experience during treatment and 
afterwards. One parent remarked that printed informa-
tion sheets never focused on details about how participa-
tion would affect their child’s day-to-day life.
Some children and young people spoke of a pronounced 
fear of needles and wanted to avoid ‘aggressive’ or ‘scary’ 
portrayals of injections in the multimedia website anima-
tions. This fear was not confined to the younger partici-
pants: one 15-year-old girl said her main question before 
deciding to participate in a trial was whether she would 
receive numbing cream before her injections. Children 
and young people also wanted information about the 
taste of oral medication, although professionals noted 
it can be difficult to give this information in advance 
for new drugs or formulations. Parents often wanted to 
know how participating would affect their child emotion-
ally and whether it would give rise to ‘undue stress’ or 
‘burden’. Some young people and parents talked about 
stress as being a crucial consideration but that it was often 
not covered in the written information they received. 
Figure 3 Website for young people and their parents
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Professionals echoed this, agreeing that most families 
wanted to know how participating in the trial would 
impact on them and what was involved.
For young people what’s often overlooked is missing 
out on things like school and social, that’s often not 
mentioned. (CYP/18)
How much time is this going to take that’s by far the 
biggest anxiety that our families have that they’re 
going to have to make extra visits to the hospital or 
extra tests to do, extra diaries to fill in at home. The 
burden to them is really important and then safety. 
(Professional/15)
When developing the multimedia websites, we included 
detailed information about what trial participation would 
involve. The websites also make it much easier to convey 
this detail with visuals and diagrams, helping to clarify 
what the family could expect if they participate in the 
trial.
What is the trial testing?
Children and young people who had first-hand experi-
ence of trials often described the science behind their 
condition and treatment and indicated an interest in 
knowing how the treatment being trialled was anticipated 
to work. Parents did not always prioritise such informa-
tion but some wanted to know whether the treatment 
had been tested before and, if so, in how many children. 
Professionals talked about the need to explain the science 
of the study in simple terms to families in order to convey 
the rationale for a trial. They emphasised the importance 
of being clear that professionals do not know the best 
treatment for a condition and that this is what the trial is 
trying to find out. In designing the multimedia websites, 
we therefore made sure that information about what the 
trial was testing was prominent and provided detailed but 
accessible information about the trial.
Risks associated with the trial—and how to inform about these
Most participants talked about the importance of having 
risks explained but wanted such information to be 
‘balanced’ so as not to unnecessarily concern prospective 
participants. Parents specifically wanted to know about the 
possible side effects associated with treatments. However, 
they also warned that there was sometimes ‘far too much 
information’ about risks and that some risks were ‘tiny’ 
but were explained in a way that could be ‘scary’ for 
young people. Young people and some children wanted 
to know exactly what they were consenting to in terms of 
risks and side effects but preferred this to focus on ‘likely’ 
risks, rather than being ‘overwhelmed’ with a list of every 
‘potential’ risk or side effect. Professionals noted that in 
their experience, families wanted to understand the risks 
and safety issues associated with being in the trial.
Well risks is mostly for, I’d say mostly for the person 
taking part because it’s going to happen to you if 
there is any possible risks. Like I know that my drug 
doesn’t always work because I’ll have a very, very bad 
box 2 topic guide for round two interviews and focus 
group discussions
Can we talk about what your first impressions of the multimedia infor-
mation resource (MMI) are?
Now I would like us to discuss different aspects of the MMI:
Visual design
 ► What do you think about how the MMI looks?
 ► What parts of the MMI appearance do you like? Which do you not 
like?
structure and navigation
 ► How did you find moving through the different parts of the MMI?
 ► How was it to find and understand information?
 ► What do you think about the mix of video, text, pictures and anima-
tion? Should anything be added or changed?
Functionality
 ► How did the MMI pages load?
 ► Were there any problems accessing the different parts of the MMI?
Content
 ► What do you think about the information content of the MMI?
 ► Do you feel it gives you enough information about what is involved 
in participating in a clinical trial?
 ► Can you tell me about anything that you think is missing from the 
MMI?
Is there anything else that you like about the MMI that we have not 
covered?
Is there anything you particularly liked about the MMI?
Is there anything that you did not like about the MMI?
What should we focus on, if anything, to improve the MMI?
Can you tell me how you think you would use the MMI?
Table 2 Summary of participant characteristics
Participant group n
Age, years
Mean (range) Gender
Experience of being 
approached about a 
children’s trial
Had taken part 
in a trial
Children and young people 21 12 (6–19) 8 male
13 female
10 8
Parents 24 – 8 male
16 female
13 12
Health professionals 17 – 4 male
13 female
n/a n/a
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flare up and that’s kind of a risk. It can’t always work 
but I think it’s really important to know that what 
could happen to you, what you’re getting yourself 
into. That just makes you feel, I don’t want to do this 
or I’m willing to do this. I think that’s really import-
ant. (CYP/23)
The risk factor thing is a huge thing, you know, to me 
some of the information sheets I’ve read I wouldn’t 
do it because I mean potentially some of those side-ef-
fects are tiny but yet the way it’s put across is so scary 
that you just wouldn’t do it. I know they have to do it, 
but is there a better way of doing that? (Parent/24)
In the multimedia websites, we therefore provided 
information about the risks within the key section about 
‘taking part in the trial’.
Possible benefits of participating in trials
Parents and young people wanted to know how trial 
participation might benefit others with the same condi-
tion, as well as the possibility of any personal benefit for 
themselves or their child. One parent emphasised that 
it was valuable for clinicians to convey this information, 
because while taking part in a trial is not always ‘easy or 
pleasant’, it is ‘important’ to future patients.
But one thing I do like about trials is that I like to 
know that the trial is going to benefit somebody in 
the future. (Parent/36)
That it’s just going to help other people if they’ve got 
problems. (CYP/16)
Sometimes families believed that their child may get 
better treatment in a trial, and this gave rise to a concern 
for some that if their child did not participate in the trial, 
or left the trial, their quality of care would be reduced. 
This indicated the continued importance of emphasising 
that children will receive good care regardless of the deci-
sion about trial participation. We therefore made sure 
that the section of the websites on the potential benefits 
of the trial was prominent and that it outlined how the 
trial findings could inform treatments for children in the 
future.
Confidentiality
Confidentiality had different meanings for different 
participants. Some parents expected that their child’s 
data would be shared among those providing care and 
that there was data sharing among all NHS organisations, 
including the family’s GP, to enable continuity of care. 
Others felt that it was not important for their GP to be 
informed of their child’s participation in a trial, with 
one parent saying GPs are ‘copied into everything’ and 
implying that such sharing of information happened auto-
matically for care provided in hospital. Young people and 
parents often said that confidentiality was important, but 
it was something that they ‘assumed’ would be observed. 
Therefore, they felt that confidentiality did not need to 
be emphasised and that other information was of a higher 
priority. Professionals did not feel that information about 
confidentiality was a priority for families, particularly for 
children and young people, when deciding to take part.
Well you kind of assume your information is confi-
dential anyway so it’s not an issue that you would en-
counter getting normal health care so you’d assumed 
the rules wouldn’t be different in a research study 
(CYP/18)… But it’s nice to be reassured about it. 
(CYP/20)
Reflecting these findings, we included information 
about confidentiality in the multimedia websites, but 
rather than giving it prominence as its own section on 
the website, it was included as one of several topics in a 
question and answer section.
Who has reviewed or funded the trial
Most children, young people and parents similarly 
assumed that quality control aspects of trials, such as 
ethical reviews, and scrutiny of funding sources, were 
carried out as a matter of course and they trusted the 
organisations running studies to scrutinise these aspects. 
However, some young people and parents talked about 
preferring hospital-led trials over commercially funded 
trials, implying information on funding sources and who 
was running a study was of interest to them. Echoing this, 
some professionals commented that families were more 
likely to join studies that were being ran by doctors they 
knew. Therefore, while most did not feel that the above 
information needed to be prominent in multimedia 
websites, access to such information could be important 
for some. Parents also felt it was important to include a 
relevant logo on the multimedia website, such as an NHS 
or local hospital logo:
If I saw that NHS logo, for me, it gives it more credi-
bility I think. (Parent/60)
Parents further emphasised the importance of knowing 
that a website their child was accessing was credible and 
explained that seeing a logo would reassure them that 
a website was reputable and safe. Young people gener-
ally were not concerned about credibility of the site but 
liked the inclusion of a logo. Given the range of views, 
we included information about who had reviewed and 
funded a study in the multimedia websites but did not 
make this prominent, and we incorporated logos into the 
websites.
Information about payments
Children and young people did not feel that information 
about the availability of incentive payments would influ-
ence their own decisions about participating. However, 
some worried that providing such payments may lead 
others to overlook the risks, and therefore that providing 
any payment to trial participants was ‘dodgy’, not to 
mention providing information about such payments. 
Professionals noted that it was rare for patients to be paid 
incentives to participate in paediatric trials in the UK. In 
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contrast, professionals and young people agreed that for 
studies involving healthy volunteers undertaking multiple 
blood tests with no personal benefit, providing informa-
tion about payments would be needed to ensure recruit-
ment. Aside from such studies, most participants did 
not believe that providing information about payments 
for participation in a trial was advisable. We positioned 
information about payments within the ‘Questions and 
Answers’ page rather than having its own specific profile 
on the website.
Design and tone of the multimedia websites
Colour
Young people felt that colour in multimedia websites was 
important to engage the audience but noted that its use 
needed balance to ensure the website looked ‘profes-
sional’. Children (aged 6–11 years) and their parents 
preferred bright colours, whereas young people preferred 
more muted colours. Some parents and professionals 
advised avoiding a particular shade of green, which they 
associated with illness. While participants liked that the 
animation characters in the prototype websites repre-
sented a range of ethnic backgrounds, ensuring the real-
istic skin tone of characters was a concern for some parents. 
Reflecting these comments, after the second round of 
interviews, we changed the skin tone for a few characters 
in the websites. We also ensured that the colours used in 
the multimedia website for children was bright (predom-
inantly orange), and the multimedia website for young 
people was more muted (predominantly teal).
Layout
Young people talked about the need for the multimedia 
websites to be well structured and easy to navigate with 
the main points ‘staring right in your face’ and having 
‘simple’ headings. They described websites that they 
liked, and even though these contained a lot of informa-
tion, it was clearly laid out and easy to read. They liked 
the relative ‘formality’ and ‘professionalism’ of the multi-
media websites and wanted the inclusion of characters 
and other images to balance out the text and make the 
websites more interesting. We ensured these aspects were 
included in the multimedia websites.
Font, characters, quirkiness and details
Young people wanted the font to be easy to read and not 
in bubble or swirly styles. Indeed, they had little tolerance 
for fonts that were difficult to read and commented that 
this would stop them from using a website. Large font 
size was particularly important for young children, and 
following their comments, we further increased the font 
size on the multimedia websites after the second round 
of interviews.
Something else that is really important is the type 
and size of font because it’s obvious that people don’t 
think about. If you can’t read the font then there is 
no point to making a website. (CYP/18)
In the first round of interviews, when showing partic-
ipants the possible character styles for the multimedia 
websites, participants stated that they wanted the charac-
ters to resemble people rather than more abstract ‘blobs’. 
Both children and young people preferred characters 
that they could ‘relate to’ and easily recognise the role 
that a character was representing:
Maybe you need a nurse that suits a teenager because 
they [nurse characters in prototype website] seem 
like they’re a children’s one with the bear. You need 
one that you can relate to. (CYP/35)
We revised some of the characters in the websites to 
ensure that the roles were easily identifiable.
Parents of young children commonly liked characters 
depicted as very simple shapes, and when elaborating 
on what it was about these that they liked, it often came 
down to them being brightly coloured. Parents of young 
people tended to dislike characters depicted as simple 
shapes, commenting that these suited children but not 
young people. However, a few young people in inter-
views corrected their parents on this, saying that they felt 
shapes could work, although most preferred characters 
that looked like people. Overall, children and young 
people were drawn to characters with brighter clothing 
and details (eg, red dress with white spots and a T-shirt 
with a lightning bolt), and we incorporated these details 
into the final website characters. Quirky or slightly unex-
pected details often received favourable responses. For 
example, the draft ‘why do we do trials’ animation often 
prompted families of young children to begin talking 
together about the animation:
It was funny wasn’t it the guy with the pan on his 
head, it’s quite funny. (Parent/41)
Funny. That was funny with the pan on his head [laugh]. 
(CYP/43)
In the multimedia websites, we included characters 
with interesting details and incorporated quirky elements 
within the other animations to make these engaging for 
families.
Animations
Conciseness was important for participants with most 
saying they would be prepared to watch animations of 
up to 90 s at a sitting, implying that longer animations 
would not hold their attention. Young people were partic-
ularly critical of repetition and some parents also found 
this distracting. A number of animations were shown to 
participants in the first round of interviews and focus 
group discussions. One animation about febrile neutro-
paenia, depicted using Lego characters and narrated by a 
child, was popular particularly with children (9–11 years) 
and their parents. Hearing the child’s voice engaged chil-
dren, even those who did not participate much in the 
interviews. However, young people often said they felt 
that this animation style and narration was a little ‘young’ 
for them. Another animation, ‘Making the right decision 
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for me’, which was narrated by a young person and 
used sounds to accompany movements and actions, was 
popular with most children, young people and parents.
It was so intriguing just like the video and what she was 
saying all went together really nicely. You could put 
yourself physically in it and just imagine it. (CYP/20)
However, one group of professionals responded very 
negatively to this particular animation commenting that 
it was ‘absolutely horrendous’ (Professional/3). The 
animation depicted a young person arguing with her 
parents when deciding whether to participate, being 
concerned about not seeing her friends due to research 
commitments, and the term ‘lab rats’ was also used at 
the beginning. These professionals felt the tone was 
unnecessarily negative and that the content was conde-
scending because it implied that assent was less impor-
tant than consent. Despite having very different views of 
this particular animation, parents, professionals, young 
people and children were united in their overall view that 
animation was a suitable means of providing information 
for all participants regardless of their age. Parents often 
talked about the benefits of seeing and hearing an anima-
tion to convey complex information that could other-
wise be challenging to explain to a child. For this reason, 
we developed four generic animations about trials and 
created a trial specific ‘explainer’ animation summarising 
the key features of a particular trial in under 60s.
I was thinking just then of watching it as an adult 
that even though it was an animation, you think ani-
mations are for children but actually when you look 
at it, sometimes when you just read something on a 
page or you’ve just got somebody speaking at you, 
it doesn’t necessarily go in easily and I would say it 
doesn’t matter that it’s an animation like that for an 
adult watching it even, because you tend to think of 
it as just for children don’t you? But they’ve made it 
[Nuffield animation] nice and simple. (Parent/32)
Narration
Young people were very sensitive to the sound and tone 
of the narrator’s voice. As previously noted, children and 
their parents liked the example animation narrated by a 
child:
I really like it because of the Lego and the child’s voice. 
That catches your attention doesn’t it? (Parent/27)
In contrast, young people and their parents felt that a 
child’s voice-over would make it hard for them to relate 
to the animation and several found it distracting if the 
pronunciation was imperfect (eg, if the child narrator 
had difficulty pronouncing some words). We therefore 
decided to have an adult’s voice narrating in the proto-
type animations. However, on viewing the prototypes, 
most young people reacted negatively to the narration, 
commenting that they disliked the ‘boring’, ‘monoto-
nous’ or ‘robotic’ tone of the narrator’s voice and that 
it stopped them from focusing on the animation itself. 
Parents did not generally focus on the voice-overs. To 
address young people’s concerns, we asked the narrator 
to record the narrations again with greater variation in 
tone.
Hearing from other families about their experience of trials
When we showed participants a short example video in 
the round one interviews of a parent and young child 
talking about participating in a trial investigating light 
treatment for vitiligo,27 most parents, young people and 
children responded favourably, commenting that hearing 
from those actually going through the trial or treatment 
was ‘reassuring’. Professionals echoed this, commenting 
that children would want to hear from and see other chil-
dren who have been in trials, rather than parents or other 
adults.
It needs to be people who are actually in trials so then 
it will put people of my age and younger under re-
assurance that other people have had a trial before. 
(CYP/51)
Reflecting these views, we created video clips of trial 
participants and their parents talking about being in a 
trial for the multimedia websites.
Interactivity
Participants differed in their opinions on the value of 
interactivity in the multimedia websites. They also varied 
in how they defined interactivity, and this may explain 
the differences in opinion. For some, interactivity meant 
including games in multimedia websites, while others 
felt it referred to being able to ask questions online and 
receive a response, and others thought it could mean 
following a pathway through the website. One young 
patient interpreted websites with multimedia to be inter-
active because you can ‘hear and see things’ rather than 
just read them.
Parents of the youngest children often wanted games, 
interactive characters and even music and singing 
included in the multimedia websites and felt that without 
this their child would not engage. Some professionals 
agreed that children would like interactivity on multi-
media websites, and this could include ‘quizzes’, ‘games’ 
or ‘being able to follow a character along a journey on the 
website’. However, when discussing preferred features of 
the websites, most young people felt that including inter-
activity would distract from its purpose unless the inter-
active features were very relevant. Some parents also felt 
that interactive aspects such as blogs and forums could be 
‘negative’ and ‘unhelpful’ unless carefully managed.
It goes one way or the other I think, either people just 
ignore it [interactivity] entirely or it’s the only thing 
they look at, neither of which are particularly useful. 
(CYP/20)
We decided against including interactivity in the 
multimedia websites, in part due to practical aspects of 
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developing and maintaining interactive components 
and due to the varied perspectives about the value of 
interactivity.
Wording is important
Careful choice of words was important so as not to scare 
children and their families. For example, parents, some 
young people and professionals felt that terms such as 
‘risk’ and ‘dangerous’ would unnecessarily worry chil-
dren and young people. To address this, in the multi-
media website for younger children, we used a heading 
of ‘Is taking part safe?’ instead of the original ‘Is taking part 
dangerous?’.
Children and young people also indicated the impor-
tance of using terminology familiar to them. For example, 
the abbreviation FAQs (frequently asked questions, which 
was used in the draft multimedia websites) meant little 
to children and young people, who preferred ‘Q&A’ or 
‘Questions and Answers’. Young people often spoke posi-
tively about the text used in the multimedia websites and 
liked the simplicity of its wording.
I like how there’s no big fancy medical words [in the 
website] because I kind of feel like that’s kind of real-
ly difficult to understand when you’re trying to read 
about what’s going to happen and they’ve got these 
massive words. You kind of feel like, for people my 
age and younger, it needs to be easy for us to under-
stand so you actually know what’s going to happen to 
us. (CYP/51)
We revised the wording on the multimedia websites 
after the second round of interviews to ensure that it was 
meaningful to children and young people.
DIsCussIOn
Main findings
We believe this is the first UK study to explore and apply 
knowledge about the views of stakeholders in developing 
multimedia websites that aim to help children and young 
people decide about clinical trial entry. Children, young 
people and parents prioritised information about what 
would happen to the participant within the trial, such as 
how the trial and the treatment being tested would affect 
them, the time commitment and potential harms and 
benefits of participation. We incorporated this informa-
tion in the multimedia website and made the prioritised 
information prominent. Participants wanted multimedia 
websites that were easy to use and engaging with plain 
language and again we incorporated these considerations 
into the design. They also valued learning from other 
young patients and their families about what it was like to 
be in a trial, and we therefore developed and incorporated 
video clips in the websites with other families talking about 
their experiences. Participants had many suggestions for 
how the websites should look, and despite some variation 
in opinion, they had clear preferences for character styles 
that resembled people, bright colours for young children 
and muted colours for young people, and we have incor-
porated these preferences in the websites. However, we 
were not able to incorporate every suggestion requested 
by participants. For example, we were unable to incorpo-
rate interactivity in the multimedia websites, despite this 
being important to parents of younger children. Further-
more, when the use of animations in the multimedia 
websites was first suggested, some parents in the round 
one interviews were concerned that young people might 
regard these as ‘too childish’. However, these concerns 
were allayed when participants in round two interviews 
viewed the prototypes, with several commenting that the 
animations were engaging and provided information in a 
way that other methods struggled to achieve.
Our findings in relation to other studies
There is limited previous research about the development of 
websites (or apps) about healthcare for children and young 
people.28–32 Findings from our study are largely in agree-
ment with the information content priorities identified in a 
previous survey of children and young people in relation to 
a hypothetical trial,32 although this survey did not explore 
priorities for the design of multimedia websites. Findings 
from previous studies33–39 of trial participation showed that 
personal benefit and helping others was important for young 
people and parents in deciding whether to participate, which 
also concurs with our findings. However, children, young 
people and parents in our study also identified information 
that was of lesser priority to them when deciding about trial 
participation, including regulatory information and partic-
ipant payments. Regarding payment, we acknowledge that 
participants’ accounts of what influences them may not 
necessarily align with influences in practice, although others 
have also reported that financial reward for trial participa-
tion was not a motivation for young people.38 We did not 
find privacy to be an important consideration for children 
and young people, which contrasts a previous survey about 
hypothetical trial decision making.32 Our findings on partic-
ipants’ priorities regarding website design, such as font and 
colour are in line with another study involving young people 
in the development of a self-management app for asthma30 
and studies showing that adults40 and young people value 
clarity in a website providing trial information.41
We used interactive techniques such as card sorting to 
facilitate participants in conveying their information prior-
ities and developed a version of the cards for younger chil-
dren that used age-appropriate language. Most children 
engaged with this process and having a parent present 
seemed to facilitate active participation of children in the 
interviews. We believe that the use of participatory design 
in this first phase of the TRECA study has resulted in multi-
media websites that are more likely to suit end users in 
the six future trials. While this remains to be confirmed, 
previous research shows that resources informed by find-
ings from participatory design are likely to be regarded as 
relevant and trustworthy by end users.31 42 43 We have also 
identified that children, young people, parents and profes-
sionals will vary in their views regarding particular aspects 
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of the multimedia websites. While some might argue that 
the views of children and young people should take prece-
dence in developing websites, and including some parents 
in our study, we worked to take account of the perspectives 
of all parties as parents and professionals may restrict chil-
dren’s and young people’s access to websites that they feel 
are unsuitable.
We did find strong divergences between participants’ 
information priorities and current UK Health Research 
Authority guidance. Of the topics explored, confidentiality 
was the area where participants’ priorities diverged most 
from the UK Health Research Authority’s guidance, which 
states that confidentiality should be covered in study infor-
mation materials. Participants’ regarded confidentiality as 
important but assumed it was observed by researchers as a 
matter of course and so it was not fundamental to inform 
their decisions about whether to take part in a trial. We 
resolved this divergence by including information about 
confidentiality in the websites but not making it prominent. 
However, we acknowledge that there may be instances when 
stakeholders’ views cannot be so easily reconciled with guid-
ance (eg, had participants wanted information about risks to 
be removed or made less prominent). We advise that when 
such divergences arise, they are dealt with on a case-by-case 
basis according to the context and reasons for the diver-
gence. The second phase of the TRECA study will involve 
further development and evaluation of the multimedia 
websites, including trials of the multimedia websites nested 
within six UK paediatric clinical trials. Embedded trials, or 
studies within a trial, enable the evaluation of trial processes 
such as recruitment techniques.44
strengths and limitations
The design of our multimedia websites was strength-
ened by interviewing children, young people, parents 
and professionals to identify their needs and preferences 
and use these to inform the development of the multi-
media websites. During interviews, we used activities and 
showed examples of animations, video, websites and char-
acter styles to facilitate children’s and young people’s 
engagement in the interviews and enable them to say 
what was important to them. We conducted two rounds 
of interviews to ensure the multimedia websites could be 
adapted and refined to incorporate the needs and pref-
erences of users. A potential weakness is that some young 
children involved in the second round of interviews had 
difficulty explaining what they liked or disliked about the 
draft websites, and the final designs may not adequately 
encompass their preferences. Nevertheless, most chil-
dren were able to convey their views on the websites. Our 
sampling was limited to two regions of the UK, and it is 
unclear how far our findings are transferable to other 
settings. However, we have tried to describe our methods 
in sufficient detail so that other researchers can consider 
the transferability of the findings to their own setting or 
implement a similar study.
Future implications
Participants were clear that receiving information via 
multimedia had several benefits over written information 
sheets, including enhancing their understanding of what 
was often complex information.
This is in line with other studies.11 14 15 The anima-
tions seemed to be particularly helpful in this respect 
as participants found them engaging, and the use of 
moving visuals and pictures allowed complex ideas to be 
explained in ways that written text alone cannot achieve. 
This has implications for how we inform children, young 
people and their families about trials and addresses the 
UK Health Research Authority’s recommendation to 
explore non-written methods of providing information 
about research so that people can access the informa-
tion most important to them before deciding whether 
to participate.13 While this study’s focus was developing 
multimedia websites for paediatric trials, there is poten-
tial benefit in using multimedia in other contexts such as 
explaining healthcare treatment.
COnClusIOns
We drew on findings from interviews with children, young 
people, parents and professionals to develop the TRECA 
multimedia websites. The findings showed that children, 
young people and parents wanted to know about what 
participation in a trial would involve, what the trial was 
testing, the potential benefits and risks of taking part 
and knowing that they could leave the trial if they later 
changed their minds. Young people and parents felt that 
regulatory and quality requirements were not priorities 
for inclusion in websites, although logos of trusted organ-
isations conveyed credibility. It was also important that 
the websites had the right tone and wording and included 
a balance of information and pictures, with interesting 
or quirky details being seen as important to encourage 
engagement with the websites.
Drawing on a participatory design has helped create 
multimedia websites that are engaging and provide infor-
mation in a way that is accessible to children, young people 
and their families. We will use the insights from this study 
to develop multimedia websites that include content for 
six UK trials and evaluate the websites for their impact 
on recruitment, retention and quality of decision making.
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